US pharmacists and physicians are getting new prescribing guidance for schedule II drugs under a DEA rule unveiled Thursday in an effort to curb the amount of spare addictive drugs lying around homes and increasing opioid addiction rates.
The new Drug Enforcement Administration final rule (RIN: 1117-AB45) lines up its regulations with the the Comprehensive Addiction and Recovery Act of 2016 and fills what the agency calls “gaps not addressed by the legislation.”
That legislation OK’d the partial filling of schedule II drug prescriptions with certain conditions. Those conditions include compliance with state law and the remainder of a ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.